One of the researchers involved in the recent large-scale study of Transcranial Magnetic Stimulation (TMS) has elaborated on the study.
Dr. John P. O’Reardon of the University of Pennsylvania School of Medicine said of the Transcranial Magnetic Stimulation study he conducted: “TMS provides a well-tolerated treatment option to patients whose depression is otherwise treatment resistant. Since TMS is administered via the scalp and therefore goes directly to the brain, it allows the patient to avoid bodily side effects such as weight gain, sedation and/or sexual function.”
Filed under: TMS researchers, transcranial magnetic stimulation
